Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Gilead Sciences Profit Margin 2006-2018 | GILD

Current and historical gross margin, operating margin and net profit margin for Gilead Sciences (GILD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Gilead Sciences net profit margin as of September 30, 2018 is 7.12%.
Gilead Sciences Annual Profit Margins
Gilead Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $88.160B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.989B 13.79
Biogen (BIIB) United States $63.816B 12.92
Celgene (CELG) United States $49.004B 9.51
Illumina (ILMN) United States $47.247B 55.04
Vertex Pharmaceuticals (VRTX) United States $44.010B 76.88
Regeneron Pharmaceuticals (REGN) United States $40.344B 20.44
Alexion Pharmaceuticals (ALXN) United States $25.790B 17.65
BioMarin Pharmaceutical (BMRN) United States $16.506B 0.00
Incyte (INCY) United States $13.728B 379.47
Seattle Genetics (SGEN) United States $9.607B 0.00
Exact Sciences (EXAS) United States $8.812B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.236B 52.66
BeiGene (BGNE) Cayman Islands $8.175B 0.00
Sarepta Therapeutics (SRPT) United States $8.111B 0.00
QIAGEN (QGEN) Netherlands $8.027B 25.67
Alnylam Pharmaceuticals (ALNY) United States $7.515B 0.00
Exelixis (EXEL) United States $6.141B 17.41
Bio-Techne Corp (TECH) United States $5.900B 39.85
Bluebird Bio (BLUE) United States $5.591B 0.00
Amarin (AMRN) Ireland $5.461B 0.00
Alkermes (ALKS) Ireland $5.285B 3401.00
Galapagos (GLPG) Belgium $5.131B 0.00
Guardant Health (GH) United States $3.860B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.481B 0.00
Immunomedics (IMMU) United States $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.341B 28.15
Horizon Pharma Public (HZNP) Ireland $3.294B 13.55
ARGENX SE-ADR (ARGX) Netherlands $3.269B 0.00
Array BioPharma (ARRY) United States $3.241B 0.00
Allogene Therapeutics (ALLO) United States $3.193B 0.00
Ligand Pharmaceuticals (LGND) United States $3.095B 23.68
Intercept Pharmaceuticals (ICPT) United States $3.032B 0.00
Akcea Therapeutics (AKCA) United States $2.830B 0.00
Ascendis Pharma (ASND) Denmark $2.720B 0.00
Repligen (RGEN) United States $2.687B 83.92
Allakos (ALLK) United States $2.638B 0.00
Genomic Health (GHDX) United States $2.633B 88.90
China Biologic Products (CBPO) China $2.544B 18.11
Blueprint Medicines (BPMC) United States $2.522B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.360B 0.00
Myriad Genetics (MYGN) United States $2.356B 23.34
MyoKardia (MYOK) United States $2.298B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.278B 0.00
Global Blood Therapeutics (GBT) United States $2.228B 0.00
Acceleron Pharma (XLRN) United States $2.226B 0.00
Halozyme Therapeutics (HALO) United States $2.186B 48.77
Arena Pharmaceuticals (ARNA) United States $2.003B 0.00
AnaptysBio (ANAB) United States $1.926B 0.00
REGENXBIO (RGNX) United States $1.879B 25.21
Amicus Therapeutics (FOLD) United States $1.878B 0.00
Denali Therapeutics (DNLI) United States $1.858B 0.00
Atara Biotherapeutics (ATRA) United States $1.835B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.820B 0.00
Innoviva (INVA) United States $1.782B 10.08
Reata Pharmaceuticals (RETA) United States $1.717B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.640B 0.00
Medicines (MDCO) United States $1.577B 0.00
Rubius Therapeutics (RUBY) United States $1.526B 0.00
Cambrex (CBM) United States $1.519B 11.35
Spark Therapeutics (ONCE) United States $1.458B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.448B 115.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.435B 0.00
WAVE Life Sciences (WVE) Singapore $1.391B 0.00
Editas Medicine (EDIT) United States $1.357B 0.00
Aimmune Therapeutics (AIMT) United States $1.354B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.340B 0.00
NeoGenomics (NEO) United States $1.320B 109.15
Mirati Therapeutics (MRTX) United States $1.272B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.268B 0.00
Myovant Sciences (MYOV) United Kingdom $1.245B 0.00
Insmed (INSM) United States $1.215B 0.00
G1 THERAPEUTICS (GTHX) United States $1.207B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.196B 0.00
Sangamo Therapeutics (SGMO) United States $1.155B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.120B 0.00
Clovis Oncology (CLVS) United States $1.120B 0.00
UniQure (QURE) Netherlands $1.117B 0.00
Lion Biotechnologies (IOVA) United States $1.105B 0.00
Fate Therapeutics (FATE) United States $1.069B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.068B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.053B 0.00
Audentes Therapeutics (BOLD) United States $1.001B 0.00
Apellis Pharmaceuticals (APLS) United States $0.997B 0.00
Retrophin (RTRX) United States $0.991B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.937B 0.00
Solid Biosciences (SLDB) United States $0.910B 0.00
Acorda Therapeutics (ACOR) United States $0.886B 11.22
Puma Biotechnology (PBYI) United States $0.884B 0.00
Gritstone Oncology (GRTS) United States $0.855B 0.00
Revance Therapeutics (RVNC) United States $0.855B 0.00
Cellectis (CLLS) France $0.843B 0.00
Intra-Cellular Therapies (ITCI) United States $0.826B 0.00
DBV Technologies (DBVT) France $0.815B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.808B 0.00
Athenex (ATNX) United States $0.807B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.799B 0.00
Novavax (NVAX) United States $0.785B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.774B 0.00
TWIST BIOSCIENC (TWST) United States $0.760B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.753B 0.00
Heska (HSKA) United States $0.751B 61.44
AC Immune SA (ACIU) Switzerland $0.734B 0.00
Vericel (VCEL) United States $0.734B 0.00
Principia Biopharma (PRNB) United States $0.722B 0.00
Aptinyx (APTX) United States $0.715B 0.00
Coherus BioSciences (CHRS) United States $0.710B 0.00
InflaRx (IFRX) Germany $0.698B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.691B 0.00
Viking Therapeutics (VKTX) United States $0.688B 0.00
Dynavax Technologies (DVAX) United States $0.661B 0.00
ANI Pharmaceuticals (ANIP) United States $0.634B 12.13
CytomX Therapeutics (CTMX) United States $0.634B 0.00
Cara Therapeutics (CARA) United States $0.631B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.631B 0.00
UROGEN PHARMA (URGN) Israel $0.621B 0.00
Scholar Rock Holding (SRRK) United States $0.608B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.604B 0.00
AVROBIO (AVRO) United States $0.602B 0.00
UNITY Biotechnology (UBX) $0.593B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.575B 0.00
BeyondSpring (BYSI) United States $0.547B 0.00
Arcus Biosciences (RCUS) United States $0.541B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.540B 0.00
Arvinas (ARVN) United States $0.537B 0.00
RA PHARMCTL INC (RARX) United States $0.533B 0.00
Kezar Life Sciences (KZR) United States $0.532B 0.00
ObsEva SA (OBSV) Switzerland $0.531B 0.00
Epizyme (EPZM) United States $0.511B 0.00
Kura Oncology (KURA) United States $0.510B 0.00
Inovio Pharmaceuticals (INO) United States $0.492B 0.00
Eidos Therapeutics (EIDX) United States $0.483B 0.00
Osiris Therapeutics (OSIR) United States $0.467B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
Replimune (REPL) United States $0.452B 0.00
Anika Therapeutics (ANIK) United States $0.449B 18.59
ZIOPHARM Oncology Inc (ZIOP) United States $0.444B 0.00
Senesco Technologies (ELOX) United States $0.438B 0.00
PDL BioPharma (PDLI) United States $0.435B 7.10
Five Prime Therapeutics (FPRX) United States $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.431B 0.00
Zymeworks (ZYME) Canada $0.420B 0.00
Mesoblast (MESO) Australia $0.419B 0.00
Kindred Biosciences (KIN) United States $0.412B 0.00
Abeona Therapeutics (ABEO) United States $0.409B 0.00
Sinovac Biotech (SVA) China $0.409B 0.00
Cytokineticsorporated (CYTK) United States $0.405B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.379B 0.00
Zealand Pharma (ZEAL) Denmark $0.377B 4.16
MediciNova (MNOV) United States $0.377B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.373B 0.00
Kodiak Sciences (KOD) United States $0.368B 0.00
Sorrento Therapeutics (SRNE) United States $0.367B 60.00
Cellular Biomedicine (CBMG) United States $0.345B 0.00
MeiraGTx Holdings (MGTX) United States $0.344B 0.00
Krystal Biotech (KRYS) United States $0.339B 0.00
ResTORbio (TORC) United States $0.338B 0.00
LogicBio Therapeutics (LOGC) United States $0.333B 0.00
Verastem (VSTM) United States $0.328B 0.00
Liquidia Technologies (LQDA) United States $0.324B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.322B 0.00
Stemline Therapeutics (STML) United States $0.317B 0.00
Agenus (AGEN) United States $0.316B 0.00
Seres Therapeutics (MCRB) United States $0.313B 0.00
Albireo Pharma (ALBO) United States $0.305B 0.00
Evelo Biosciences (EVLO) United States $0.290B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.288B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
Geron (GERN) United States $0.278B 0.00
Kadmon Holdings (KDMN) United States $0.266B 0.00
Equillium (EQ) United States $0.266B 0.00
Athersys (ATHX) United States $0.264B 0.00
Merus (MRUS) Netherlands $0.262B 0.00
Magenta Therapeutics (MGTA) United States $0.260B 0.00
Syros Pharmaceuticals (SYRS) United States $0.258B 0.00
TOCAGEN INC (TOCA) United States $0.258B 0.00
BioDelivery Sciences (BDSI) United States $0.257B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.253B 0.00
Arbutus Biopharma (ABUS) Canada $0.244B 0.00
Celcuity (CELC) United States $0.243B 0.00
Intec Pharma (NTEC) Israel $0.241B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Celyad SA (CYAD) Belgium $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.229B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.218B 0.00
Aduro Biotech (ADRO) United States $0.213B 0.00
Axovant Sciences (AXON) United Kingdom $0.209B 0.00
PSivida (EYPT) United States $0.209B 0.00
Urovant Sciences (UROV) United States $0.206B 0.00
Kamada (KMDA) Israel $0.205B 18.87
Synlogic (SYBX) United States $0.199B 0.00
Allena Pharmaceuticals (ALNA) United States $0.192B 0.00
Kala Pharmaceuticals (KALA) United States $0.191B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.190B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.185B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.177B 0.00
Unum Therapeutics (UMRX) United States $0.176B 0.00
ChromaDex (CDXC) United States $0.175B 0.00
Proteostasis Therapeutics (PTI) United States $0.174B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.172B 0.00
Compugen (CGEN) Israel $0.169B 0.00
Idera Pharmaceuticals (IDRA) United States $0.165B 0.00
Protagonist Therapeutics (PTGX) United States $0.163B 0.00
Constellation Pharmaceuticals (CNST) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.152B 0.00
Cohbar (CWBR) United States $0.149B 0.00
XBiotech (XBIT) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.144B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Cerecor (CERC) United States $0.138B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.126B 0.00
XOMA (XOMA) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
NantKwest (NK) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.120B 0.00
Pluristem Therapeutics (PSTI) Israel $0.120B 0.00
Eleven Biotherapeutics (SESN) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.118B 0.00
Mersana Therapeutics (MRSN) United States $0.118B 0.00
Applied Genetic Technologies (AGTC) United States $0.118B 0.00
Spero Therapeutics (SPRO) United States $0.116B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.113B 0.00
Cocrystal Pharma (COCP) United States $0.110B 122.67
ETON PHARMACEUT (ETON) United States $0.104B 0.00
Motif Bio Plc (MTFB) United States $0.103B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.103B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Signal Genetics (MGEN) United States $0.098B 0.00
Anavex Life Sciences (AVXL) United States $0.098B 0.00
Cue Biopharma (CUE) United States $0.097B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Mustang Bio (MBIO) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.092B 0.00
Neothetics (EVFM) United States $0.092B 0.00
ScPharmaceuticals (SCPH) United States $0.088B 0.00
Axsome Therapeutics (AXSM) United States $0.088B 0.00
Chiasma (CHMA) United States $0.087B 0.00
Orgenesis (ORGS) United States $0.087B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.084B 0.00
OVID THERAPEUTC (OVID) United States $0.084B 0.00
Aptose Biosciences (APTO) Canada $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
BioXcel Therapeutics (BTAI) United States $0.074B 0.00
ITUS (ANIX) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Ophthotech (OPHT) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
Fortress Biotech (FBIO) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.063B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
Evogene (EVGN) Israel $0.061B 0.00
AEterna Zentaris (AEZS) United States $0.060B 11.47
Alcobra (ARCT) United States $0.059B 0.00
Monster Digital (INNT) United States $0.058B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Trevena (TRVN) United States $0.052B 0.00
Versartis (ARAV) United States $0.051B 4.51
Arsanis (ASNS) United States $0.050B 0.00
Aptevo Therapeutics (APVO) United States $0.050B 0.00
OncoSec Medical (ONCS) United States $0.048B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Caladrius Biosciences (CLBS) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Celsion (CLSN) United States $0.040B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.038B 6.13
Galena Biopharma (SLS) United States $0.038B 0.00
Oncolytics Biotech (ONCY) Canada $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.035B 0.00
TRACON Pharmaceuticals (TCON) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
VIVUS (VVUS) United States $0.032B 0.00
GTx (GTXI) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Histogenics (HSGX) United States $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Advaxis (ADXS) United States $0.020B 0.00
CytRx (CYTR) United States $0.019B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.018B 9.21
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Cellect Biotechnology (APOP) Israel $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Edge Therapeutics (EDGE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Adial Pharmaceuticals (ADIL) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
MYOS RENS Technology (MYOS) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00